Impact of desflurane removal from the operating room on carbon dioxide emissions at a tertiary academic medical centre: a retrospective cohort study.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 40675839.
- Also identified by DOI 10.1016/j.bja.2025.05.031.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Inhalational anaesthesia agents contribute to healthcare-related greenhouse gas emissions. We evaluated the carbon footprint of inhalation anaesthesia at a US academic medical centre over time and determined the relative importance of institutional measures (removal of desflurane and limiting fresh gas flow [FGF] and nitrous oxide [N<sub>2</sub>O] use) to reduce carbon dioxide equivalent emissions (CO<sub>2</sub>e-emissions). From 124 428 patients undergoing inhalational anaesthesia between 2014 and 2022, CO<sub>2</sub>e-emissions per patient were calculated from minute-by-minute recordings of inspiratory concentrations of sevoflurane, isoflurane, desflurane, and N<sub>2</sub>O, as well as FGF data. Data were combined with the global warming potential for each gas. Interrupted time series analysis, adjusted for patient and procedural factors, was applied to assess the impact of gradual removal of desflurane from operating rooms in June 2018 and its complete elimination in January 2020. From June 2014 to June 2022, mean CO<sub>2</sub>e-emissions per patient decreased by 82.8% from an average of 83.1 (median, 23.6 [interquartile range, 10.1-107.8]) kg to 14.3 (median 8.5 [4.2-15.9]) kg. In adjusted analyses, restrictive use of desflurane (-1.53 kg per patient, 95% confidence interval, -1.88 to -1.18; P<0.001) and its subsequent elimination (additional -0.50 kg per patient, -0.80 to -0.19; P=0.002) reduced CO<sub>2</sub>e-emissions. Before the elimination, desflurane was the main contributor to CO<sub>2</sub>e-emissions (74% relative contribution). After the elimination, use of N<sub>2</sub>O (73%) and high FGF (>3.42 L min<sup>-1</sup>, 4%) emerged as dominant predictors of CO<sub>2</sub>e-emissions. Eliminating desflurane led to a substantial reduction in anaesthesia-related CO<sub>2</sub>e-emissions of ∼900 metric tonnes annually. This study highlights the importance of volatile anaesthetic choice and factors including N<sub>2</sub>O use and fresh gas flow to minimise the carbon footprint of anaesthesia.
Medical subject headings
- Desflurane
- Anesthetics, Inhalation
- Carbon Dioxide
- Operating Rooms
- Anesthesia, Inhalation